---
category: listing
circular_id: 003bcb7dd3db3866
date: '2025-07-30'
description: NSE announces listing of 2,669,951 equity shares of Astec LifeSciences
  Limited allotted under Rights Issue, effective July 31, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML69399.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard listing circular for rights issue shares - affects existing
  shareholders and trading liquidity
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML69399.pdf
processing:
  attempts: 1
  content_hash: 975f57e243c42cba
  processed_at: '2025-07-30T18:46:44.455901'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-07-30T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML69399.pdf
severity: low
source: nse
stocks:
- ASTEC
tags:
- listing
- rights-issue
- equity-shares
- astec-lifesciences
title: Listing of further issues of Astec LifeSciences Limited
---

## Summary

NSE has announced the listing of 2,669,951 additional equity shares of Astec LifeSciences Limited (Symbol: ASTEC) allotted under a Rights Issue. The shares will be available for trading on the Capital Market segment from July 31, 2025, with an issue price of Rs. 890 per share.

## Key Points

- 2,669,951 equity shares of Rs. 10/- face value each to be listed
- Issue price: Rs. 890 per share
- Date of allotment: July 29, 2025
- Distinctive number range: 19611711 to 22281661
- Market lot size: 1 share
- Shares are pari passu with existing equity shares
- ISIN: INE563J01010

## Regulatory Changes

No regulatory changes introduced. Standard listing procedure under existing NSE Capital Market Trading Regulations.

## Compliance Requirements

- Trading members must use designated security codes for identification
- Trading must be conducted in specified lot sizes
- Shares initially credited under temporary ISIN as per SEBI circulars CIR/MRD/DP/21/2012 and CIR/MRD/DP/24/2012

## Important Dates

- Allotment date: July 29, 2025
- Trading commencement: July 31, 2025
- Circular effective date: July 31, 2025

## Impact Assessment

The listing increases Astec LifeSciences' total tradeable shares, potentially improving liquidity. Rights issue shareholders can now trade their allotted shares. The high issue price of Rs. 890 suggests strong investor confidence in the company's prospects.